Abstract. The human oral cavity harbors one of the most diverse microbial ecosystems in the body, comprising over 700 named bacterial species as well as fungi, viruses, and archaea. Advances in next-generation sequencing have transformed our understanding of this community — shifting the paradigm from a focus on individual pathogens to the ecological dynamics of the microbiome as a whole. This article reviews current evidence on oral microbiome composition, the concept of dysbiosis, and emerging clinical implications for dental practice and systemic health.
Key Findings from the Literature
- The Human Oral Microbiome Database (HOMD), maintained by the Forsyth Institute, has catalogued over 700 bacterial species across 13 phyla from the human oral cavity. Of these, approximately 57% have been formally named and cultivated; the remainder have been identified exclusively through sequencing. The core oral microbiome — those species present in the majority of healthy adults — is estimated to comprise around 100–200 species.
- A landmark study published in Cell Host & Microbe (2021) using metagenomic sequencing of saliva samples from 1,200 adults found that oral microbiome composition was highly individual and remained relatively stable over 12 months in health, but that dysbiotic shifts preceded clinical periodontitis by a mean of 4.2 months, suggesting potential as an early biomarker of disease risk.
- Research published in Nature Communications (2022) demonstrated that Porphyromonas gingivalis — a key periodontal pathogen — can act as a keystone pathogen: even at low abundance, it can orchestrate dysbiotic shifts in the wider community by suppressing host immune responses, enabling less virulent organisms to establish pathogenic biofilms. This finding has significant implications for understanding why periodontitis can progress despite low counts of classically pathogenic species.
- A prospective cohort study in Gut (2022) found that specific oral microbial signatures — particularly elevated Fusobacterium nucleatum and reduced Streptococcus salivarius — were associated with a 2.3-fold increased risk of colorectal cancer over 10 years, independent of dietary and lifestyle factors. F. nucleatum has also been identified in colorectal tumor tissue, raising questions about a potential causal role.
- Clinical trials published in Journal of Clinical Periodontology (2020–2023) examining probiotic supplementation with Lactobacillus reuteri and Streptococcus salivarius K12 found statistically significant reductions in gingival bleeding indices and probing depths in patients with chronic gingivitis, with effect sizes comparable to adjunctive antimicrobial mouth rinses — suggesting microbiome-targeted interventions may offer viable therapeutic alternatives to pharmacological approaches.
- Salivary microbiome profiling is now being evaluated as a non-invasive diagnostic tool for conditions beyond periodontitis. Pilot studies have demonstrated discriminatory accuracy for pancreatic cancer, rheumatoid arthritis, and Sjögren’s syndrome using oral microbial signatures, with area-under-the-curve values ranging from 0.82 to 0.94 in early-stage validation cohorts.
Clinical Significance
The ecological model of oral disease — sometimes termed the polymicrobial synergy and dysbiosis (PSD) hypothesis — represents a significant conceptual shift from earlier models that attributed periodontitis to a small number of specific pathogens. In the ecological framework, disease arises not from the presence of particular organisms per se, but from perturbations in community composition that disrupt the host-microbiome equilibrium. This has meaningful implications for treatment strategy: rather than targeting individual pathogens with antimicrobials, approaches that restore community balance may prove more durable.
The clinical utility of microbiome profiling is currently limited by the absence of validated, standardized reference ranges and the high inter-individual variability in the healthy oral microbiome. Point-of-care salivary diagnostics remain largely in the research phase, though commercial saliva-based tests for periodontal risk stratification are beginning to emerge. The pace of development in this area suggests that microbiome-informed clinical decision-making will become increasingly feasible within the next decade.
Of immediate practical relevance to clinicians is the recognition that antibiotic prescribing practices in dentistry have microbiome consequences that extend beyond the oral cavity. Systemic antibiotics disrupt the intestinal microbiome, and evidence suggests that orally-administered amoxicillin significantly reduces oral microbial diversity for up to 30 days post-treatment. This should be factored into prescribing decisions, particularly for prophylactic use.
What This Means for Patients
For patients, the emerging microbiome science reinforces several well-established principles of oral hygiene while also pointing toward new directions in prevention and treatment. Mechanical plaque control — brushing and interdental cleaning — remains the most effective method of disrupting dysbiotic biofilm formation. The role of diet in shaping the oral microbiome is also increasingly recognized: fermentable carbohydrates selectively enrich acidogenic species associated with caries, while dietary fiber and polyphenols appear to support commensal populations.
At Fridman Family Dental Care in Valencia, CA, our approach to preventive care is grounded in the understanding that maintaining a healthy oral microbiome begins with consistent daily hygiene and regular professional maintenance. For patients with a history of gum disease or recurrent caries, personalized prevention strategies — including dietary guidance, probiotic recommendations, and more frequent maintenance intervals — can help maintain microbiome stability over time. For more on the relationship between gum disease and general health, see: What Are the Signs of Gingivitis? and Laser Gum Treatment: The Modern Solution for Gum Health.
Patients interested in understanding how their oral health connects to systemic wellness are encouraged to ask about our comprehensive periodontal assessment at their next visit. For a broader discussion of how oral conditions relate to overall health, see our patient guide: How Does Diabetes Affect Oral Health?
References
- Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–5017. doi:10.1128/JB.00542-10
- Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–725. doi:10.1038/nrmicro2873
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–759. doi:10.1038/s41579-018-0089-x
- Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol. 1965;36(3):177–187. doi:10.1902/jop.1965.36.3.177
- Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27(6):409–419. doi:10.1111/j.2041-1014.2012.00663.x
This article is intended for informational purposes and reflects published clinical literature as of the date of writing. It does not constitute individualized medical or dental advice. Patients should consult a licensed dental professional to discuss their specific clinical situation.
